Table 1 Annual total number of paediatric isolates (invasive + non-invasive) received by the SRLP, total no. (%) of paediatric middle ear fluid isolates (MEF), and among them, no. (%) of PCV7 and 19A isolates.
| Ā | 97-00 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|
Total no. | 2342 | 758 | 874 | 802 | 1196 | 1374 | 1136 | 1326 | 1291 | 749 |
MEF [n (%)] | 481 (20.5) | 210 (27.7) | 171 (19.6) | 159 (19.8) | 180 (15.1) | 166 (12.1) | 176 (15.5) | 173 (13.0) | 220 (17.0) | 141 (18.8) |
āāā< 2 yrs. | 253 (52.6) | 121 (57.6) | 81(47.4) | 69 (43.4) | 81 (45.0) | 91 (54.8) | 97 (55.1) | 95 (54.9) | 153 (69.5) | 86 (61.0) |
āāā2-4 yrs. | 68 (14.1) | 43 (20.5) | 49 (28.7) | 34 (21.4) | 46 (25.6) | 26 (15.7) | 50 (28.4) | 51 (29.5) | 44 (20.0) | 35 (24.8) |
āāā5-14 yrs. | 160 (33.3) | 46 (21.9) | 41 (24.0) | 56 (35.2) | 53 (29.4) | 49 (29.5) | 29 (16.5) | 27 (15.6) | 23 (10.5) | 20 (14.2) |
PCV-7 [n (%)]* | 340 (70.7) | 132 (62.9) | 109 (63.7) | 77 (48.4) | 64 (35.6) | 40 (24.1) | 33 (18.8) | 23 (13.3) | 22 (10.0) | 15 (10.6) |
āāā< 2 yrs. | 186 (54.7) | 86 (65.2) | 59 (54.1) | 37 (48.1) | 35 (54.7) | 23 (57.5) | 11 (33.3) | 10 (43.5) | 15 (68.2) | 10 (66.7) |
āāā2-4 yrs. | 54 (15.9) | 20 (15.2) | 30 (27.5) | 13 (16.9) | 16 (25.0) | 7 (17.5) | 12 (36.4) | 10 (43.5) | 5 (22.7) | 2 (13.3) |
āāā5-14 yrs. | 100 (29.4) | 26 (19.7) | 20 (18.3) | 27 (35.1) | 13 (20.3) | 10 (25.0) | 10 (30.3) | 3 (13.0) | 2 (9.1) | 3 (20.0) |
19A [n (%)]* | 32 (6.7) | 20 (9.5) | 21 (12.3) | 27 (17.0) | 38 (21.1) | 53 (31.9) | 55 (31.3) | 67 (38.7) | 103 (46.8) | 50 (35.5) |
āāā< 2 yrs. | 18 (56.3) | 14 (70.0) | 9 (42.9) | 14 (51.9) | 20 (52.6) | 35 (66.0) | 41 (74.5) | 48 (71.6) | 80 (77.7) | 42 (84.0) |
āāā2-4 yrs. | 3 (9.4) | 3 (15.0) | 4 (19.0) | 6 (22.2) | 7 (18.4) | 5 (9.4) | 10 (18.2) | 11 (16.4) | 19 (18.4) | 7 (14.0) |
āāā5-14 yrs. | 11 (34.4) | 3 (15.0) | 8 (38.1) | 7 (25.9) | 11 (28.9) | 13 (24.5) | 4 (7.3) | 8 (11.9) | 4 (3.9) | 1 (2.0) |